Picture of Instil Bio logo

TIL — Instil Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Instil Bio Inc reports results for the quarter ended in March - Earnings Summary

* Instil Bio Inc  TIL.OQ  reported a quarterly adjusted loss
of 44
cents​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of 15
cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Instil Bio Inc's reported EPS for the quarter was a loss
of 44
cents​.
    * The mean earnings estimate of analysts had risen by
about 53% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Instil Bio Inc shares had fallen by 7.2% this quarter and
lost 2.7% so far this year.
    * The company reported a quarterly loss of $57.07 million.
    * Wall Street's median 12-month price target for Instil Bio
Inc is
$5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
15 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.15          -0.44          Missed
 Dec. 31 2022      -0.41          -0.24          Beat
 Sep. 30 2022      -0.44          -0.43          Beat
 Jun. 30 2022      -0.41          -0.46          Missed

Recent news on Instil Bio

See all news